| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Paliperidone palmitate |
| Brand | Xeplion® |
| Indication | For maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone. In selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, Xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate, and a long acting injectable treatment is needed. |
| Assessment Process | |
| Rapid review commissioned | 23/03/2011 |
| Rapid review completed | 09/04/2011 |
